DIMENSIONAL FUND ADVISORS LP

Holdings History for Atea Pharmaceuticals, Inc. - Common Stock (AVIR)

Symbol: AVIR on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$4,904,865	1,373,946	-166,770	-11%	$3.57	Q4 2025
30 Sep 2025	0%	+0%	$4,468,201	1,540,716	+129,453	+9.2%	$2.90	Q3 2025
30 Jun 2025	0%	+0%	$5,079,620	1,411,263	+227,537	+19%	$3.60	Q2 2025
31 Mar 2025	0%	+0%	$3,538,970	1,183,726	+206,256		$2.99	Q1 2025
31 Dec 2024	0%	+0%	$3,274,401	977,470	+183,844	+23%	$3.35	Q4 2024
30 Sep 2024	0%	+0%	$2,659,204	793,626	+199,266	+34%	$3.35	Q3 2024
30 Jun 2024	0%	+0%	$1,967,764	594,360	+211,428	+55%	$3.31	Q2 2024
31 Mar 2024	0%	+0%	$1,547,044	382,932	+290,581	+315%	$4.04	Q1 2024
31 Dec 2023	0%	0%	$281,670	92,351	0		$3.05	Q4 2023
30 Sep 2023	0%	0%	$277,053	92,351	0		$3.00	Q3 2023
30 Jun 2023	0%	+0%	$345,393	92,351	+30,712	+50%	$3.74	Q2 2023
31 Mar 2023	0%	+0%	$206,491	61,639	+61,639	NEW	$3.35	Q1 2023
30 Jun 2021		-0%	$0	0	-3,683	-100%	$4.15	Q2 2021
31 Mar 2021	0%	+0%	$227,000	3,683	+3,683	NEW	$61.63	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.